GlobeNewswire Inc.··Beyond Air, Inc.Peer-Reviewed Study Validates High-Dose Inhaled Nitric Oxide for Respiratory Infections
Peer-reviewed study validates Beyond Air's high-dose inhaled nitric oxide for treating respiratory infections including pneumonia, COVID-19, and bronchiolitis, supporting regulatory advancement.
XAIRclinical trialshigh-dose inhaled nitric oxide